Mafenide microbiology: Difference between revisions

Latest revision as of 05:00, 9 January 2014

Mafenide
MAFENIDE ACETATE^® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Adapted from the FDA Package Insert.

Revision as of 05:00, 9 January 2014 (view source) Chetan Lokhande (talk \| contribs) (Created page with "__NOTOC__ {{Mafenide}} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web \| last = \| first = \| title = MAFENIDE ACETATE POWDER, FOR SOLUTION [PAR P...")		Latest revision as of 05:00, 9 January 2014 (view source) Chetan Lokhande (talk \| contribs) No edit summary
(One intermediate revision by the same user not shown)
Line 2:		Line 2:
	{{Mafenide}}		{{Mafenide}}
	{{CMG}}; {{AE}} {{chetan}}		{{CMG}}; {{AE}} {{chetan}}